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Predictive Analytics of Phosphoproteins in Breast Cancer Cells
Cells respond to their environment by activating signaling
networks that trigger processes such as growth, survival,
apoptosis (cell death), and migration. Post-translational
modifications, notably phosphorylation, play a key role in
signaling. In cancer cells, signaling networks frequently
become compromised, leading to abnormal behaviors and
responses to external stimuli. Advancing our understanding
of how these networks are deregulated across cancer cells
will ultimately lead to more effective treatment strategies for
patients. There is an urgent need for computational
approaches that can characterize causal signaling networks
using data acquired in a specific background or context of
interest. There is also a need to address the related task of
predicting dynamical trajectories in specific contexts and
under specific perturbations. In the Dialogue on Reverse
Engineering Assessment and Methods (DREAM) challenge
8, participants were given breast cancer data and asked to
use the data to build models that can predict trajectories of
protein levels following inhibitor perturbation(s) not included
in the training data. Data were acquired under 8 stimuli
(Serum, PBS, EGF, Insulin, FGF1, HGF, NRG1, IGF1), and
inhibition of network nodes by one of 3 inhibitors (AKT, [AKT
+ MEK], [FGFR1, FGFR3]) or DMSO vehicle control (cells
were serum-starved and pre-treated with inhibitor prior to
ligand stimulation). The experiment was carried out on 4
breast cancer cell lines (MCF7, UACC812, BT20, and
BT549), with abundance of ~45 phosphoproteins measured
at 7 time points post-stimulus. This poster presents the
results of the predictions using multivariate statistic (partial
least squares regression), compared to other methods.
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Materials and Methods
Objective
Experimental breast cancer proteomic data
Dataset was generated using Reverse Phase Protein Array
(RPPA) quantitative proteomics technology. The experiment
design is shown in Figure 1.
• Data were acquired under 8 stimuli (Serum, PBS, EGF,
Insulin, FGF1, HGF, NRG1, IGF1)
• Inhibition by one of 3 inhibitors (AKT, [AKT + MEK], [FGFR1,
FGFR3])
• 4 breast cancer cell lines (MCF7, UACC812, BT20, BT549)
• Abundance of 45 phosphoproteins (proteins phosphorylated
at specific sites) measured.
• Measured at 7 time points post-stimulus (0 min, 5 min, 15
min, 1 hr, 2 hr, 4 hr).
Figure 1.  An overview of the experimental design to 
generate the dataset.
Method
Partial least squares regression (PLS) Figure 2
• PLS takes into account latent structure in both 
datasets
• Xi are the k explanatory variables
• Yj are the p dependent variables
• The model is linear   ynj = 
• βi are found differently from linear regression 
Figure 2. The overview of PLS regression
Results
The objective is to build dynamical models that
can predict trajectories of phosphoproteins. An
important emphasis is on the ability of models
to generalize beyond the training data by
predicting trajectories under perturbations not
included in the training data.
Conclusions
• PLS method effectively predicted phosphoproteins in cancer cells
that were not included in the training data.
• PLS method was among the best methods for phosphoproteins 
predictions.
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